Monday, 4 April 2016

Global Fibrin Sealants Market Strategies, Size And Forecasts to 2020

Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen and Factor XIII, which combine with a solution of calcium and thrombin to form a coagulum that stimulates clotting.

Beriplast P and TISSEEL are some of the commercially available fibrin sealants. The report analysts forecast the global fibrin sealants market to grow at a CAGR of 9.14% during the period 2016-2020.

Covered in this report:

The report covers the present scenario and the growth prospects of the global fibrin sealants market for 2016-2020. To calculate the market size, the report considers the revenue generated from fibrin sealants from the following regions:
  •  Americas
  •  APAC
  •  EMEA
Global Fibrin Sealants Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Read more reports of this category:

Key vendors
  •  Baxter International
  •  CSL Behring
  •  Johnson & Johnson (Ethicon)
Other prominent vendors
  •  Asahi Kasei Medical
  •  C.R. Bard (Bard Medical, Davol)
  •  Harvest Technologies
  •  Kaketsuken
  •  LifeBond
  •  Pharming Group
  •  Sea Run
  •  Shanghai RAAS
  •  STB Lifesaving Technologies
  •  Tissuemed
  •  Z-Medica
Key questions answered in this report
  •  What will the market size be in 2020 and what will the growth rate be?
  •  What are the key market trends?
  •  What is driving this market?
  •  What are the challenges to market growth?
  •  Who are the key vendors in this market space?
  •  What are the market opportunities and threats faced by the key vendors?
  •  What are the strengths and weaknesses of the key vendors?

No comments:

Post a Comment